Finch Therapeutics Group Inc (FNCH)
12.05
+0.10
(+0.84%)
USD |
OTCM |
Nov 05, 15:01
Finch Therapeutics Group Enterprise Value: 3.154M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.154M |
| November 01, 2024 | 3.476M |
| October 31, 2024 | 3.235M |
| October 30, 2024 | 3.074M |
| October 29, 2024 | 2.432M |
| October 28, 2024 | 2.833M |
| October 25, 2024 | 3.154M |
| October 24, 2024 | 3.235M |
| October 23, 2024 | 3.235M |
| October 22, 2024 | 3.476M |
| October 21, 2024 | 3.684M |
| October 18, 2024 | 3.316M |
| October 17, 2024 | 3.316M |
| October 16, 2024 | 3.315M |
| October 15, 2024 | 3.235M |
| October 14, 2024 | 2.673M |
| October 11, 2024 | 2.432M |
| October 10, 2024 | 2.432M |
| October 09, 2024 | 2.432M |
| October 08, 2024 | 2.432M |
| October 07, 2024 | 2.432M |
| October 04, 2024 | 2.737M |
| October 03, 2024 | 2.913M |
| October 02, 2024 | 3.074M |
| October 01, 2024 | 2.432M |
| Date | Value |
|---|---|
| September 30, 2024 | 3.194M |
| September 27, 2024 | 2.432M |
| September 26, 2024 | 1.629M |
| September 25, 2024 | 1.629M |
| September 24, 2024 | 1.629M |
| September 23, 2024 | 1.773M |
| September 20, 2024 | 2.271M |
| September 19, 2024 | 2.673M |
| September 18, 2024 | 2.368M |
| September 17, 2024 | 2.432M |
| September 16, 2024 | 2.432M |
| September 13, 2024 | 2.110M |
| September 12, 2024 | 2.689M |
| September 11, 2024 | 2.833M |
| September 10, 2024 | 3.349M |
| September 09, 2024 | 4.102M |
| September 06, 2024 | 4.102M |
| September 05, 2024 | 5.081M |
| September 04, 2024 | 5.194M |
| September 03, 2024 | 4.551M |
| August 30, 2024 | 4.535M |
| August 29, 2024 | 5.948M |
| August 28, 2024 | 4.519M |
| August 27, 2024 | 3.556M |
| August 26, 2024 | 2.576M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-53.41M
Minimum
Dec 23 2022
907.23M
Maximum
Mar 19 2021
116.09M
Average
-7.057M
Median
Apr 28 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.834M |
| Total Expenses (Quarterly) | 6.109M |
| EPS Diluted (Quarterly) | -3.01 |
| Earnings Yield | -73.19% |
| Normalized Earnings Yield | -402.11 |